{"database": "lobbying", "table": "lobbying_activities", "rows": [[1119225, "56bb2b4c-5770-4f00-baae-29f51d17af19", "Q2", "THE PETRIZZO GROUP, INC.", 305932, "FATE THERAPEUTICS, INC.", 2011, "second_quarter", "MED", "Advocated for funding to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.", "Defense Advanced Research Projects Agency (DARPA),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2011-07-18T20:12:18.380000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1119225"], "units": {}, "query_ms": 1.4385409886017442, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}